Distribution of metabolic syndrome (MS) components by age and gender Zhao D, et al. Am J Cardiol 2007;100:835– 839.

Slides:

Advertisements

Similar presentations

Sibbing D, et al. J Am Coll Cardiol 2009;53:

Advertisements

Baseline Characteristics According to CET Rate Marianne Zeller, et al. J Am Coll Cardiol 2007;50:

Literature Search Strategy Used for the MEDLINE Database Gami AS, et al. J Am Coll Cardiol 2007;49:

Admission B-Type Natriuretic Peptide Levels and In-Hospital Mortality in Acute Decompensated Heart Failure Fonarow GC et al. J Am Coll Cardiol 2007; 49(19):

Metabolic Syndrome in Non-Diabetics Vilanova Fillat, M.B. Falguera Vilamajó, M. Garriga Badia, A. Miró Vallvé, N. Cebrian Aiguadé, C. Escardó Font, C Bacompte.

Key messages Stephen S Lim, et al. Lancet 2007; 370:

Ian Graham et al. European Heart Journal 2007;28:

Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?

Cardiovascular Disease in Women Module I: Epidemiology.

Characteristics of 3921 Men Seen by a Primary Care Provider Steven A. Grover, et al, Arch Intern Med. 2005;166:

Quartiles of complete blood count components Jeffrey L. Anderson, et al. Am J Cardiol 2007;99:

How can you estimate simply the cardiovascular risk of your patients?

Double Jeopardy. International Diabetes Federation Diabetes State of raised blood glucose (hyperglycaemia) associated with premature mortality Pancreas.

Baseline Prevalence of Metabolic Syndrome and Individual Components Among 4258 Older Adults Dariush Mozaffarian, et al. Arch Intern Med. 2008;168:

Slide Source: Lipids Online Slide Library C-Reactive Protein, Metabolic Syndrome, and Risk for CV Events: Women’s Health Study 14,719.

Trial profile Prakash Deedwania, et al. Lancet 2006; 368:

The CHART-2 Study (The Chronic Heart Failure Analysis and Registry in the Tohoku District 2) Source Shiba N, Nochioka K, Miura M, et al. Trend of westernization.

Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Effectiveness of Pharmacist Interventions on.

Date of download: 6/22/2016 Copyright © The American College of Cardiology. All rights reserved. From: Exercise at the Extremes: The Amount of Exercise.

Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: The CardioMetabolic Health Alliance: Working Toward.

Date of download: 6/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: The metabolic syndrome, diabetes, and subclinicalatherosclerosis.

Date of download: 9/17/2016 Copyright © The American College of Cardiology. All rights reserved. From: Potential Impact of Time Trend of Life-Style Factors.

The Management of Comorbid Conditions in Patients with Rheumatoid Arthritis Cardiovascular Risk.

Adapted from Weiss et al. J Am Coll Cardiol. 1998;31:

Obesity Trends* Among U.S. Adults BRFSS, 1985

Nat. Rev. Cardiol. doi: /nrcardio

C‐Reactive Protein Identifies Low‐Risk Metabolically Healthy Obese Persons: The European Prospective Investigation of Cancer–Norfolk Prospective Population.

Effect of Obesity on In-Hospital Mortality in Patients with Cardiogenic Shock Complicating AMI Obesity is paradoxically associated with favorable mortality.

Figure 5 BMI and cardiorespiratory fitness levels

Figure 4 BMI and mortality in patients with heart failure

Figure 1 Experimental design

Nat. Rev. Cardiol. doi: /nrcardio

Figure 3 Global rates of sodium, fruit, and vegetable intake

Figure 3 Ischaemic outcomes in the ST-segment elevation myocardial

Nat. Rev. Endocrinol. doi: /nrendo

Figure 2 Three-year survival rates on the basis of body composition

Figure 4 Effects of delaying cardioprotective medications after anthracycline administration Figure 4 | Effects of delaying cardioprotective medications.

Figure 2 Ischaemic and bleeding outcomes in the major clinical trials

Nat. Rev. Cardiol. doi: /nrcardio

Figure 1 Cardiovascular risk and disease across the life-course

Description of studies for pooled analyses

Example of algorithm for clinical assessment of patients at risk of non-alcoholic fatty liver disease Example of algorithm for clinical assessment.

Fung TT, et al. Circulation 2009;119:

Figure 2 Absolute difference in seasonal peak

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 6 Combining population-wide and high-risk strategies

Apple or Pear: Size and Shape Matter

Example of algorithm for clinical assessment of patients at risk of non-alcoholic fatty liver disease Example of algorithm for clinical assessment.

Patient characteristics in the entire study group

Baseline Characteristics of Cardiovascular Risk Factors and Selected Dietary Variables in a Cohort of 22,881 Men and 35,091 Women to Quintile of Fish Intakes.

Nat. Rev. Cardiol. doi: /nrcardio

Baseline Patients with coronary artery disease (CAD) and high (n=98) versus normal (n=1512) high-density lipoprotein (HDL) levels Doreen DeFaria Yeh, et.

Baseline Characteristics of Study Subjects

Nat. Rev. Cardiol. doi: /nrcardio

Clinical Epidemiology and Global Health

Correlation between plasma C reactive protein (CRP) and angiopoietin-like protein 4 (ANGPTL4). Correlation between plasma C reactive protein (CRP) and.

(A) Absolute and (B) change from baseline in 6 min walk distance over time for all patients and by Down syndrome status. (A) Absolute and (B) change from.

Baseline characteristics of the 1,842 men without coronary heart disease and the 230 men with a first coronary heart disease event during the 13-year.

Anuurad E, et al. Am J Cardiol 2009;103:523-7

Plasma levels of GLP-1 are increased in patients with critical illness and correlate with disease severity. Plasma levels of GLP-1 are increased in patients.

Measures which increase adiponectin, increase GLP-1 activity, control metabolic syndrome and activate hepatic AMPK or PPARalpha may decrease elevated TMAO.

Demographic Characteristics of Patients Treated With Statins Versus Those Not Treated With Statins Goldberger JJ, et al. J Am Coll Cardiol 2006;48:

Increase of physical activity over time associated with lower HF risk

Risk for cardiovascular disease and all-cause death according to RHR: (A) as categorical variable (HR≥75 bpm vs HR

Comparison of conventional population-based, high-risk and motivational population-wide cardiovascular disease (CVD) prevention strategies. Comparison.

Distribution and change of the underlying disease in patients discharged with home mechanical ventilation (n = 854). ♦: chronic obstructive pulmonary disease;

Prevalence of nephropathy, retinopathy, and neuropathy in subjects achieving all (A) three targets, (B) two targets, (C) one target, and (D) none, and.

The cumulative incidence curve demonstrated that patients with a sub-optimal LDL-C response to statin therapy were associated with a higher risk of CVD.

Distribution of points (%) across the ESSDAI domains in patients with neurological involvement and in those with non-neurological systemic involvement.

Presentation transcript:

Distribution of metabolic syndrome (MS) components by age and gender Zhao D, et al. Am J Cardiol 2007;100:835– 839

Comparison of risk factors between patients with metabolic syndrome (MS) with and without central obesity Zhao D, et al. Am J Cardiol 2007;100:835– 839

Correlation matrix of five components of metabolic syndrome Zhao D, et al. Am J Cardiol 2007;100:835– 839

Levels of metabolic disorders by status of different metabolic syndrome (MS) components Zhao D, et al. Am J Cardiol 2007;100:835– 839

Ten-year absolute cardiovascular risk in two metabolic syndrome (MS) groups Zhao D, et al. Am J Cardiol 2007;100:835– 839

Ten-year relative risk of cardiovascular disease (CVD) by status of components of metabolic syndrome Zhao D, et al. Am J Cardiol 2007;100:835– 839